Discover key insights from Basilea Pharmaceutica AG's Q4 2024 earnings call. Learn about robust revenue growth, FDA approvals, and pipeline advancements.
Visteon Corporation (NASDAQ: VC) today reported fourth quarter and full-year 2024 financial results. Highlights ...
Service revenue is reported on the income statement under operating revenues, reflecting earnings from core business ...
HighlightsSales increased 2% to $10.6 billion, in-line with global light vehicle productionDiluted earnings per share of ...
Unearned revenue is a liability because it represents a company’s obligation to deliver goods or services in the future.
Revenues up 115% year-over-year to a record $1.01 billion.Q4 Net Deposits grow to a record $16 billion.Q4 Gold Subscribers up 86% ...
Under project finance guidelines, banks were required to set aside 5% as provisions for loans given for infrastructure and ...
(k), IRA, or individual stocks? Learn which investment vehicle to prioritize for your retirement savings and financial goals.
Aim-traded financial services group Tavistock Investments (TAVI:3.7p) transformed its finances last autumn by selling its financial advisory and estate planning businesses to private-equity-backed ...
The Italian bank said it expected net profit to be broadly in line with 2024’s result despite an expected dip in revenue as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results